Depression of PHA response in patients during therapeutic infection with MP virus.
D002277:Carcinoma / Q000628:therapy; D006801:Humans; D037102:Lectins / Q000494:pharmacology*; D008175:Lung Neoplasms / Q000628:therapy; D008213:Lymphocyte Activation / Q000187:drug effects*; D008217:Lymphocytic choriomeningitis virus; D008223:Lymphoma / Q000628:therapy; D009369:Neoplasms / Q000628:therapy*
D037102:Lectins